Application of a new method for analysis of exhaled gas in critically ill patients

被引:91
作者
Schubert, JK [1 ]
Muller, WPE [1 ]
Benzing, A [1 ]
Geiger, K [1 ]
机构
[1] Univ Hosp Freiburg, Dept Anaesthesiol & Intens Care Med, D-79106 Freiburg, Germany
关键词
acetone; gas chromatography; isoprene; lipid peroxidation; microwave desorption; N-pentane;
D O I
10.1007/s001340050589
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Application of a new method for analysis of exhaled gas in critically ill patients. Design: Open study. Setting: Surgical intensive care unit of an university hospital. Patients: Thirty-seven consecutive, critically ill, mechanically ventilated patients. Interventions: None. Measurements and results: Chemical analysis of the patient's exhaled gas was based upon substance adsorption and concentration onto activated charcoal, microwave desorption and gas chromatographic separation. Patients with acute respiratory distress syndrome (ARDS) exhaled less isoprene than those without ARDS [9.8 (8.2-21.6) vs 21.8 (13.9-41.4) nmol/m(2) per min [median (95 % confidence interval)], p = 0.04]. In patients who developed pulmonary infection, pentane elimination increased from 0.4 (0.0-5.4) to 2.7 (0.6-6.1, p = 0.05) nmol/m(2) per min and isoprene elimination decreased from 5.2 (0-33) to 5.0 (0-17, p = 0.05) nmol/m(2) per min, resulting in a significant increase in pentane/isoprene ratio from 0.1 (0-0.3) to 0.4 (0-15, p = 0.007) when compared to patients without pulmonary infection. Conclusions: The new method allows quantitative analysis of human gas samples with low substance concentrations and is well suited for clinical studies which involve the investigation of metabolic processes in the lung and the body.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 31 条
[1]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[2]   IS PENTANE A NORMAL CONSTITUENT OF HUMAN BREATH [J].
CAILLEUX, A ;
ALLAIN, P .
FREE RADICAL RESEARCH COMMUNICATIONS, 1993, 18 (06) :323-327
[3]   DECREASE OF ISOPRENE CONCENTRATIONS IN BLOOD DURING GENERAL-ANESTHESIA [J].
CAILLEUX, A ;
MOREAU, X ;
DELHUMEAU, A ;
ALLAIN, P .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993, 49 (03) :321-325
[4]   ISOPRENE AND SLEEP [J].
CAILLEUX, A ;
ALLAIN, P .
LIFE SCIENCES, 1989, 44 (24) :1877-1880
[5]   ISOPRENE, AN ENDOGENOUS CONSTITUENT OF HUMAN ALVEOLAR AIR WITH A DIURNAL PATTERN OF EXCRETION [J].
DEMASTER, EG ;
NAGASAWA, HT .
LIFE SCIENCES, 1978, 22 (01) :91-98
[6]  
Euler DE, 1996, CLIN CHEM, V42, P303
[7]   Breath isoprene: Temporal changes in respiratory output after exposure to ozone [J].
Foster, WM ;
Jiang, L ;
Stetkiewicz, PT ;
Risby, TH .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 80 (02) :706-710
[8]   VOLATILE LIPID OXIDATION-PRODUCTS [J].
FRANKEL, EN .
PROGRESS IN LIPID RESEARCH, 1983, 22 (01) :1-33
[9]   ETHANE PRODUCTION-RATE INVIVO IS REDUCED WITH DIETARY RESTRICTION [J].
HABIB, MP ;
DICKERSON, F ;
MOORADIAN, AD .
JOURNAL OF APPLIED PHYSIOLOGY, 1990, 68 (06) :2588-2590
[10]   DETERMINATION OF ISOPRENE IN HUMAN BREATH BY THERMAL-DESORPTION GAS-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
JONES, AW ;
LAGESSON, V ;
TAGESSON, C .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1995, 672 (01) :1-6